Evidence map›Paper›PMID 26585833›Full record

ArticleScientific reports2015

Position-specific automated processing of V3 env ultra-deep pyrosequencing data for predicting HIV-1 tropism.

Nicolas Jeanne, Adrien Saliou, Romain Carcenac, Caroline Lefebvre, Martine Dubois, Michelle Cazabat, Florence Nicot, Claire Loiseau, Stéphanie Raymond, Jacques Izopet and 1 more

Abstract read
In one paragraph

Article in Scientific reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Nicolas JeanneLaboratoire de Virologie, Hôpital Purpan, Toulouse, F-31300 France.
Adrien SaliouLaboratoire de Virologie, Hôpital Purpan, Toulouse, F-31300 France.
Romain CarcenacLaboratoire de Virologie, Hôpital Purpan, Toulouse, F-31300 France.
Caroline LefebvreLaboratoire de Virologie, Hôpital Purpan, Toulouse, F-31300 France.
Martine DuboisLaboratoire de Virologie, Hôpital Purpan, Toulouse, F-31300 France.
Michelle CazabatLaboratoire de Virologie, Hôpital Purpan, Toulouse, F-31300 France.
Florence NicotLaboratoire de Virologie, Hôpital Purpan, Toulouse, F-31300 France.
Claire LoiseauINSERM, UMR1043, Toulouse, F-31300 France.
Stéphanie RaymondLaboratoire de Virologie, Hôpital Purpan, Toulouse, F-31300 France.
Jacques IzopetLaboratoire de Virologie, Hôpital Purpan, Toulouse, F-31300 France.
Pierre DelobelINSERM, UMR1043, Toulouse, F-31300 France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

HIV-1 coreceptor usage must be accurately determined before starting CCR5 antagonist-based treatment as the presence of undetected minor CXCR4-using variants can cause subsequent virological failure. Ultra-deep pyrosequencing of HIV-1 V3 env allows to detect low levels of CXCR4-using variants that current genotypic approaches miss. However, the computation of the mass of sequence data and the need to identify true minor variants while excluding artifactual sequences generated during amplification and ultra-deep pyrosequencing is rate-limiting. Arbitrary fixed cut-offs below which minor variants are discarded are currently used but the errors generated during ultra-deep pyrosequencing are sequence-dependant rather than random. We have developed an automated processing of HIV-1 V3 env ultra-deep pyrosequencing data that uses biological filters to discard artifactual or non-functional V3 sequences followed by statistical filters to determine position-specific sensitivity thresholds, rather than arbitrary fixed cut-offs. It allows to retain authentic sequences with point mutations at V3 positions of interest and discard artifactual ones with accurate sensitivity thresholds.

Indexed as

Amino Acid SequenceCyclohexanesGenotypeHigh-Throughput Nucleotide SequencingHIV-1HIV Envelope Protein gp120HIV Fusion InhibitorsHIV InfectionsHost-Pathogen InteractionsHumansMaravirocMolecular Sequence DataPeptide FragmentsPhenotypePoint MutationReceptors, CCR5CCR5 protein, humanCXCR4 protein, humanCyclohexanesHIV Envelope Protein gp120HIV envelope protein gp120 (305-321)HIV Fusion InhibitorsMaravirocPeptide FragmentsReceptors, CCR5Receptors, CXCR4Triazoles

Identifiers

PMID26585833
PMCPMC4653658

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.